UBS Raises Price Target on AMN Healthcare Services (AHS) to $48.50; Reiterates Buy

August 5, 2016 10:09 AM EDT
Get Alerts AHS Hot Sheet
Price: $33.02 -1.32%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade AHS Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

UBS reiterated a Buy rating on AMN Healthcare Services (NYSE: AHS), and raised the price target to $48.50 (from $42.00). following the company's 2Q earnings report. EPS of $0.61 was $0.09 ahead of consensus estimates. Revenues grew to $474M, beating the Street by $18M.

Analyst A.J. Rice commented, "AHS posted 2Q adj. cash EPS of $0.61, up 60% Y/Y and $0.09 ahead of UBSe/cons. 2Q16 revs grew 35% Y/Y (19% organic) to $474 mln, $20/$18 mln ahead of UBSe/cons. Adj EBITDA margin improved 130 bps Y/Y to 12.5%, 100 bps above UBSe. Higher revs/strong margins drove a 51% Y/Y increase in adj EBITDA to $59.3 mln, $7.0 mln above UBSe. Overall, the qtr's results, the 3Q16 outlook, and management's tone on the 2Q call suggest demand for AHS's medical staffing services remain very strong."

For an analyst ratings summary and ratings history on AMN Healthcare Services click here. For more ratings news on AMN Healthcare Services click here.

Shares of AMN Healthcare Services closed at $41.93 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS, Earnings

Add Your Comment